|

Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis

RECRUITINGSponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Actively Recruiting
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Started2024-07-26
Est. completion2027-06-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06517979

Summary

The goal of this diagnostic test is to develop an artificial intelligence (AI)-based pan-cancer universal diagnostic model for detecting pathological lymph node metastasis (LNM), and prospectively evaluate its apllication value in the real-world clinical practice. Investigators will compare the diagnostic performance (sensitivity, specificity, etc.) of the AI model and routine pathological report issued by pathologists, to see if the AI model can improve the clinical workflow of pathological evaluation of cancer LNM in in the real world.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with cancer, undergoing radical tumor resection and lymph node dissection.
* Patients with complete clinical and pathological information.

Exclusion Criteria:

* The patient refused to participate in this diagnostic test.

Conditions2

CancerLymphatic Metastasis

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.